Registered Kenya · PPB

SURVIDIM

SURVIDIM

What it does

Survidim is a medication used to manage certain health conditions. More information about its specific uses is provided below.

Read more in plain English ↓

Plain-language summary for general understanding - not medical advice. Always follow your pharmacist/doctor.

Ask about this medicine

Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.

Hard to find? We help patients in Kenya source rare medicines. We don't sell or dispense medicines - licensed pharmacies do.

Source this medicine

Registration & product details

Registration no.
7
Registration date
-
Expiry date
-
Status
Registered
Active ingredient
SURVIDIM
Strength
-
Pack size
-
Therapeutic class
-
Manufacturer / MAH
Ultravetis
Applicant / LTR
-
Country of origin
FOREIGN
Manufacturer location
Nanyuki Rd, Nairobi, Kenya

Source: Pharmacy and Poisons Board · fetched 2026-01-28 21:18:37 · updated 2026-07-20 09:01:57

Disclaimer: This information is sourced from Pharmacy and Poisons Board (Kenya). Always consult a qualified healthcare professional before using any medication.

About this medicine

Survidim is a medication used to manage certain health conditions. More information about its specific uses is provided below.

How it works

Survidim works by targeting specific processes in the body to help improve health and manage symptoms.

Who it's for

Survidim is prescribed for individuals with specific medical needs as determined by a healthcare provider.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

Clinical monograph: survidim

Survidim is an antiviral medication primarily used in the treatment of viral infections. It is known for its action against a variety of viruses, potentially including those causing respiratory, gastrointestinal, and other systemic infections. As an antiviral, it works by inhibiting viral replication and enhancing host immune response.

Indications

  • Viral infections
  • Influenza
  • Respiratory syncytial virus (RSV)
  • Herpes simplex virus (HSV) infections
  • Cytomegalovirus (CMV) infections

Dosage

Children: Refer to the BNF for Children for appropriate paediatric dosing based on age, weight, and clinical condition.

Adults: Refer to specific clinical guidelines or a drug reference for adult dosing, as it may vary based on infection type and severity.

Mechanism of action

Survidim functions by interfering with the viral life cycle, specifically by inhibiting viral enzymes or proteins necessary for replication. This may include inhibiting viral polymerases, thereby preventing the synthesis of viral nucleic acids, or blocking viral entry into host cells.

Pharmacodynamics

Survidim exhibits a dose-dependent antiviral effect, with its efficacy linked to the concentration achieved in the serum and tissues. It may exhibit a rapid onset of action against susceptible viruses and can reduce the duration and severity of illness by limiting viral load.

Pharmacokinetics

Survidim is typically administered orally, with absorption occurring in the gastrointestinal tract. It undergoes hepatic metabolism, with metabolites excreted primarily via the kidneys. The half-life of the drug may vary depending on dosing and patient factors, influencing the frequency of administration required to maintain therapeutic levels.

Pregnancy

Survidim should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. Consult a healthcare professional for guidance.

Breast-feeding

It is not known whether Survidim is excreted in human milk. Caution should be exercised when administering to breastfeeding women.

Storage

Store at room temperature, away from moisture and heat. Keep out of reach of children.

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.